DESONIDE

N/A

Manufactured by Actavis Pharma, Inc.

14,012 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DESONIDE

DESONIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Actavis Pharma, Inc.. The most commonly reported adverse reactions for DESONIDE include DRUG INEFFECTIVE, MACULAR DEGENERATION, OFF LABEL USE, PAIN, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DESONIDE.

Top Adverse Reactions

DRUG INEFFECTIVE1,136 reports
MACULAR DEGENERATION773 reports
OFF LABEL USE397 reports
PAIN376 reports
NAUSEA364 reports
HEADACHE313 reports
ERYTHEMA299 reports
PYREXIA298 reports
RASH297 reports
PRURITUS293 reports
PSORIASIS278 reports
MALAISE276 reports
WEIGHT DECREASED275 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE257 reports
ABDOMINAL PAIN221 reports
CHRONIC SINUSITIS216 reports
DERMATITIS ATOPIC210 reports
CONSTIPATION205 reports
DYSPEPSIA203 reports
FATIGUE203 reports
INFUSION RELATED REACTION200 reports
PARAESTHESIA ORAL200 reports
ANAEMIA197 reports
DIARRHOEA189 reports
PROCEDURAL PAIN182 reports
HAEMATOCHEZIA168 reports
RECTAL HAEMORRHAGE167 reports
FREQUENT BOWEL MOVEMENTS162 reports
COLITIS160 reports
COLITIS ULCERATIVE160 reports
FEMALE GENITAL TRACT FISTULA159 reports
RADICULOPATHY158 reports
DRY SKIN156 reports
ORAL CANDIDIASIS156 reports
VAGINAL DISCHARGE153 reports
PROCTITIS151 reports
VAGINAL FLATULENCE151 reports
SKIN EXFOLIATION139 reports
CONDITION AGGRAVATED130 reports
ARTHRALGIA126 reports
PRODUCT USE IN UNAPPROVED INDICATION124 reports
ECZEMA113 reports
PRODUCT DOSE OMISSION ISSUE104 reports
DYSPNOEA101 reports
INJECTION SITE PAIN100 reports
PNEUMONIA100 reports
CHRONIC KIDNEY DISEASE92 reports
DIZZINESS92 reports
ALOPECIA86 reports
PAIN IN EXTREMITY85 reports
DEATH83 reports
VOMITING83 reports
ANXIETY82 reports
ASTHENIA79 reports
FALL79 reports
DEPRESSION78 reports
COUGH76 reports
URTICARIA76 reports
INSOMNIA74 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION73 reports
RENAL FAILURE73 reports
INCORRECT DOSE ADMINISTERED64 reports
ACUTE KIDNEY INJURY63 reports
URINARY TRACT INFECTION62 reports
DRY EYE61 reports
BACK PAIN60 reports
EYE PRURITUS60 reports
PSORIATIC ARTHROPATHY59 reports
SINUSITIS59 reports
PRODUCT USE ISSUE58 reports
OCULAR HYPERAEMIA57 reports
SLEEP DISORDER57 reports
TREATMENT FAILURE57 reports
PERIPHERAL SWELLING56 reports
DISCOMFORT55 reports
NASOPHARYNGITIS55 reports
EMOTIONAL DISTRESS54 reports
THERAPEUTIC RESPONSE DECREASED54 reports
INFECTION53 reports
ABDOMINAL DISCOMFORT52 reports
RASH PRURITIC51 reports
DERMATITIS50 reports
EYE IRRITATION48 reports
HYPERSENSITIVITY48 reports
WEIGHT INCREASED48 reports
HYPERTENSION47 reports
PARAESTHESIA47 reports
SOMNOLENCE47 reports
MUSCLE SPASMS46 reports
COVID 1945 reports
SKIN BURNING SENSATION45 reports
SKIN DISORDER45 reports
ABDOMINAL PAIN UPPER44 reports
DRUG HYPERSENSITIVITY44 reports
BRONCHITIS43 reports
CONJUNCTIVITIS43 reports
DECREASED APPETITE43 reports
INFLUENZA43 reports
CHEST PAIN41 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION41 reports

Report Outcomes

Out of 4,710 classified reports for DESONIDE:

Serious 56.2%Non-Serious 43.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female2,807 (64.7%)
Male1,527 (35.2%)
Unknown5 (0.1%)

Reports by Age

Age 71149 reports
Age 65119 reports
Age 6961 reports
Age 5759 reports
Age 6457 reports
Age 6654 reports
Age 5653 reports
Age 6253 reports
Age 6751 reports
Age 6850 reports
Age 4249 reports
Age 7347 reports
Age 6346 reports
Age 5045 reports
Age 5145 reports
Age 5945 reports
Age 5344 reports
Age 6044 reports
Age 7044 reports
Age 6143 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DESONIDE?

This profile reflects 14,012 FDA FAERS reports that mention DESONIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DESONIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, MACULAR DEGENERATION, OFF LABEL USE, PAIN, NAUSEA, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DESONIDE?

Labeling and FAERS entries often list Actavis Pharma, Inc. in connection with DESONIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.